首页 > 最新文献

Journal of Mental Health Policy and Economics最新文献

英文 中文
Cost-Effectiveness of Transcranial Magnetic Stimulation for Methamphetamine Use Disorder during Pregnancy. 经颅磁刺激治疗妊娠期甲基苯丙胺使用障碍的成本-效果。
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2025-12-01
Rana Jawish, Abdelrahman G Tawfik, Brian Mickey, Adam J Gordon, Robert Silver, Marcela C Smid, Casey R Tak
<p><strong>Background: </strong>Methamphetamine use disorder (MUD) during pregnancy is associated with adverse maternal and perinatal outcomes, including increased risk of preterm birth, cesarean delivery, neonatal intensive care unit admission, placental abruption, and maternal or perinatal death. For the few evidence-based treatments for MUD, including transcranial magnetic stimulation (TMS) and injectable naltrexone with bupropion combination, there are few data available for pregnant individuals.</p><p><strong>Aims of the study: </strong>We completed an exploratory model applying existing knowledge in clinical practice and available research to examine the potential cost-effectiveness of TMS compared to the combination of injectable naltrexone with bupropion or care as usual in a population of pregnant individuals with MUD. We aim to utilize the outcome of this analysis to inform future trial designs that examine TMS efficacy and safety in MUD during pregnancy.</p><p><strong>Methods: </strong>A decision tree model was developed to evaluate the direct medical costs and clinical outcomes of TMS compared to injectable naltrexone with bupropion or usual care for pregnant individuals with MUD. The analysis included three strategies from the start of pregnancy through delivery, focusing on mode of delivery, gestational age, and infant birth weight. The primary outcome was the percentage of full-term vaginal deliveries of infants with normal birth weight. The analysis was conducted from a third-party payer perspective, considering only direct medical costs, and used a $50,000 willingness-to-pay threshold to determine cost-effectiveness.</p><p><strong>Results: </strong>In this experimental model, TMS demonstrated the lowest overall cost and highest effectiveness, yielding 76% full-term vaginal deliveries with normal-weight infants, compared to 44% for injectable naltrexone with bupropion combination and 39% for no intervention. Sensitivity analyses confirmed the robustness of TMS as a cost-effective intervention.</p><p><strong>Discussion: </strong>Our exploratory model found that TMS was cost-effective compared to injectable naltrexone and bupropion or usual care, potentially improving outcomes at low costs. This study provides preliminary data supporting TMS being a promising cost saving option for MUD during pregnancy. The study's limitations include absence of direct TMS efficacy data in pregnant populations, necessitating the use of extrapolated data, small sample size, and short-term nature of efficacy data in non-pregnant populations. Additionally, there was insufficient data on the adverse effects of the interventions on fetuses and infants, highlighting the need for studies to confirm safety and efficacy.</p><p><strong>Implications for health care provision and use: </strong>Both TMS and the combination of injectable naltrexone and bupropion show potential for treating pregnant individuals with MUD. However, neither treatment is FDA-approved
背景:妊娠期甲基苯丙胺使用障碍(MUD)与孕产妇和围产期不良结局相关,包括早产、剖宫产、新生儿重症监护病房入院、胎盘早剥和孕产妇或围产期死亡风险增加。对于少数循证治疗MUD的方法,包括经颅磁刺激(TMS)和注射纳曲酮与安非他酮的组合,孕妇的数据很少。研究目的:我们完成了一个探索性模型,应用临床实践中的现有知识和现有研究来检查经颅磁刺激与注射纳曲酮联合安非他酮或常规护理在怀孕的MUD个体人群中的潜在成本效益。我们的目标是利用这一分析的结果,为未来的试验设计提供信息,以检验经颅磁刺激在妊娠期MUD中的疗效和安全性。方法:建立决策树模型,比较经颅磁刺激与注射纳曲酮联合安非他酮或常规护理对妊娠期MUD患者的直接医疗费用和临床结果。该分析包括从怀孕开始到分娩的三种策略,重点是分娩方式、胎龄和婴儿出生体重。主要结局是正常出生体重的婴儿足月阴道分娩的百分比。该分析是从第三方付款人的角度进行的,仅考虑直接医疗费用,并使用5万美元的支付意愿阈值来确定成本效益。结果:在该实验模型中,经颅磁刺激显示出最低的总成本和最高的有效性,正常体重婴儿的足月阴道分娩率为76%,相比之下,注射纳曲酮与安非他酮联合为44%,无干预为39%。敏感性分析证实了经颅磁刺激作为一种具有成本效益的干预措施的稳健性。讨论:我们的探索性模型发现,与注射纳曲酮和安非他酮或常规护理相比,经颅磁刺激具有成本效益,可能以低成本改善结果。这项研究提供了初步的数据,支持经颅磁刺激是一个有希望的节省成本的选择,在怀孕期间的MUD。该研究的局限性包括缺乏直接的经颅磁刺激在怀孕人群中的疗效数据,需要使用外推数据,样本量小,以及非怀孕人群中疗效数据的短期性。此外,关于干预措施对胎儿和婴儿的不良影响的数据不足,强调需要进行研究以确认安全性和有效性。对卫生保健提供和使用的影响:经颅磁刺激和可注射纳曲酮和安非他酮的组合显示出治疗孕妇MUD的潜力。然而,这两种治疗方法都没有获得fda批准,也没有在这一人群中进行广泛的研究。如果经颅磁刺激被证明是一种具有成本效益和安全的治疗选择,它可以显著改善孕产妇和围产期结局。对卫生政策的影响:将孕妇排除在MUD临床试验之外限制了对这一人群的治疗证据。资助大型临床试验是至关重要的,重点是孕妇与MUD。进一步研究的意义:关于经颅磁刺激和注射纳曲酮与安非他酮对胎儿和婴儿的安全性的数据有限。未来的研究对于更新这一模型,确认安全性和有效性,探索妊娠期MUD的围产期结局,确保对这一人群的最佳护理至关重要。
{"title":"Cost-Effectiveness of Transcranial Magnetic Stimulation for Methamphetamine Use Disorder during Pregnancy.","authors":"Rana Jawish, Abdelrahman G Tawfik, Brian Mickey, Adam J Gordon, Robert Silver, Marcela C Smid, Casey R Tak","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Methamphetamine use disorder (MUD) during pregnancy is associated with adverse maternal and perinatal outcomes, including increased risk of preterm birth, cesarean delivery, neonatal intensive care unit admission, placental abruption, and maternal or perinatal death. For the few evidence-based treatments for MUD, including transcranial magnetic stimulation (TMS) and injectable naltrexone with bupropion combination, there are few data available for pregnant individuals.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aims of the study: &lt;/strong&gt;We completed an exploratory model applying existing knowledge in clinical practice and available research to examine the potential cost-effectiveness of TMS compared to the combination of injectable naltrexone with bupropion or care as usual in a population of pregnant individuals with MUD. We aim to utilize the outcome of this analysis to inform future trial designs that examine TMS efficacy and safety in MUD during pregnancy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A decision tree model was developed to evaluate the direct medical costs and clinical outcomes of TMS compared to injectable naltrexone with bupropion or usual care for pregnant individuals with MUD. The analysis included three strategies from the start of pregnancy through delivery, focusing on mode of delivery, gestational age, and infant birth weight. The primary outcome was the percentage of full-term vaginal deliveries of infants with normal birth weight. The analysis was conducted from a third-party payer perspective, considering only direct medical costs, and used a $50,000 willingness-to-pay threshold to determine cost-effectiveness.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;In this experimental model, TMS demonstrated the lowest overall cost and highest effectiveness, yielding 76% full-term vaginal deliveries with normal-weight infants, compared to 44% for injectable naltrexone with bupropion combination and 39% for no intervention. Sensitivity analyses confirmed the robustness of TMS as a cost-effective intervention.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Discussion: &lt;/strong&gt;Our exploratory model found that TMS was cost-effective compared to injectable naltrexone and bupropion or usual care, potentially improving outcomes at low costs. This study provides preliminary data supporting TMS being a promising cost saving option for MUD during pregnancy. The study's limitations include absence of direct TMS efficacy data in pregnant populations, necessitating the use of extrapolated data, small sample size, and short-term nature of efficacy data in non-pregnant populations. Additionally, there was insufficient data on the adverse effects of the interventions on fetuses and infants, highlighting the need for studies to confirm safety and efficacy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Implications for health care provision and use: &lt;/strong&gt;Both TMS and the combination of injectable naltrexone and bupropion show potential for treating pregnant individuals with MUD. However, neither treatment is FDA-approved ","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"28 4","pages":"125-132"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146012720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PERSPECTIVE: Self-Funded Group Health Plans: A Public Mental Health Threat to Employees? 观点:自费团体健康计划:对员工的公共心理健康威胁?
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2025-12-01
Meiram Bendat, Katherine G Kennedy

With nearly one in four Americans estimated to have a mental illness and only half of them receiving treatment in a given year, access to affordable, quality mental health care remains out of reach for many. Although health insurance is intended to promote access to mental health care, approximately 35 million Americans covered by self-funded group health plans sponsored by private employers may be unaware that their health plans are not subject to federal standards for medical necessity and network adequacy, key terms that determine the availability of coverage and can significantly limit their access to essential treatment. The Employee Retirement and Security Act of 1974 ("ERISA") governing self-funded group health plans does not require them to base their definitions of medical necessity for covered services on generally accepted standards of care. Nor does ERISA require them to follow or disclose network adequacy standards. To the extent network adequacy standards are often undisclosed, if they exist at all, plan participants can be exposed to significant out-of-network financial liabilities when in-network mental health services are unavailable. ERISA's judicial review provisions further disadvantage plan participants by requiring courts to defer to employer benefit interpretations and by severely restricting available relief. To improve access to affordable, high quality mental healthcare for participants in self-funded health plans, the following reforms are crucial: a federal definition of medical necessity, time and distance standards for network adequacy, hold harmless provisions for out-of-network costs due to network inadequacy, and removal of restrictions on judicial review and available remedies.

据估计,近四分之一的美国人患有精神疾病,其中只有一半人在一年中接受过治疗,许多人仍然无法获得负担得起的高质量精神卫生保健。虽然健康保险的目的是促进获得精神保健服务,但由私人雇主赞助的自费团体健康计划所覆盖的大约3 500万美国人可能不知道,他们的健康计划不受医疗必要性和网络充足性的联邦标准的约束,这些关键条款决定了保险的可获得性,并可能严重限制他们获得基本治疗的机会。管理自筹资金的团体健康计划的1974年《雇员退休和安全法》("ERISA")并不要求这些计划将承保服务的医疗必要性定义建立在普遍接受的护理标准之上。ERISA也没有要求他们遵循或披露网络充分性标准。在某种程度上,网络充分性标准往往未被披露,如果它们存在的话,当网络内的心理健康服务不可用时,计划参与者可能面临重大的网络外财务负债。ERISA的司法审查规定要求法院遵从雇主福利解释,并严格限制可获得的救济,这进一步使计划参与者处于不利地位。为了使自筹资金健康计划的参与者更容易获得负担得起的高质量精神保健,必须进行以下改革:联邦政府对医疗必要性的定义、网络充分性的时间和距离标准、对因网络充分性而造成的网络外费用的规定不予损害,以及取消对司法审查和现有补救办法的限制。
{"title":"PERSPECTIVE: Self-Funded Group Health Plans: A Public Mental Health Threat to Employees?","authors":"Meiram Bendat, Katherine G Kennedy","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>With nearly one in four Americans estimated to have a mental illness and only half of them receiving treatment in a given year, access to affordable, quality mental health care remains out of reach for many. Although health insurance is intended to promote access to mental health care, approximately 35 million Americans covered by self-funded group health plans sponsored by private employers may be unaware that their health plans are not subject to federal standards for medical necessity and network adequacy, key terms that determine the availability of coverage and can significantly limit their access to essential treatment. The Employee Retirement and Security Act of 1974 (\"ERISA\") governing self-funded group health plans does not require them to base their definitions of medical necessity for covered services on generally accepted standards of care. Nor does ERISA require them to follow or disclose network adequacy standards. To the extent network adequacy standards are often undisclosed, if they exist at all, plan participants can be exposed to significant out-of-network financial liabilities when in-network mental health services are unavailable. ERISA's judicial review provisions further disadvantage plan participants by requiring courts to defer to employer benefit interpretations and by severely restricting available relief. To improve access to affordable, high quality mental healthcare for participants in self-funded health plans, the following reforms are crucial: a federal definition of medical necessity, time and distance standards for network adequacy, hold harmless provisions for out-of-network costs due to network inadequacy, and removal of restrictions on judicial review and available remedies.</p>","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"28 4","pages":"121-124"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146012746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-Utility of Repetitive Transcranial Magnetic Stimulation (rTMS) among Treatment Resistant Depression Patients. 反复经颅磁刺激(rTMS)治疗难治性抑郁症患者的成本-效用。
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2025-12-01
Anna-Kaisa Vartiainen, Elisa Rissanen, Ismo Linnosmaa
<p><strong>Background: </strong>Depression has a high prevalence worldwide and because of its recurrent nature, it represents a major economic burden on society. It is important to identify and evaluate effective treatments to avoid the health disutilities and costs related to poor health. Repetitive transcranial magnetic stimulation (rTMS) is a neuromodulatory technique which is clinically safe, non-invasive, and effective for major depressive disorder and it is used for treatment after at least two failed antidepressant medication trials. The availability of rTMS treatment is still limited in many countries.</p><p><strong>Aims of the study: </strong>The main study objective was to evaluate the cost-effectiveness of add-on rTMS therapy compared with pharmacotherapy in patients with treatment-resistant depression in Finland from a societal perspective.</p><p><strong>Methods: </strong>A one-year Markov-model with two-month cycles was analysed to compare costs and quality adjusted life years (QALYs). Medical and productivity costs were included in the analysis. The data for the model (transition probabilities, resource utilization, utilities) were sourced from published literature, a national unit cost report, and Finnish expert opinions. Incremental cost-effectiveness ratio was calculated. Uncertainty was assessed using univariate and multivariate probabilistic sensitivity analyses and scenario analyses.</p><p><strong>Results: </strong>rTMS patients gained an average of 0.041 additional QALYs over one year time horizon with an incremental cost of 3,514 EUR compared to pharmacotherapy alone. The result corresponds to incremental cost-effectiveness ratio (ICER) of 85,133 EUR per QALY. Sensitivity analysis points out that one of the key parameters relating to uncertainty and driving ICER is the high unit cost of rTMS treatment.</p><p><strong>Discussion: </strong>rTMS as an add-on treatment for depression has a beneficial clinical effect compared to pharmacotherapy alone, with greater costs. However, ICER was very high suggesting that rTMS may not be cost-effective acute treatment for TRD patients in Finland. If the unit cost of the rTMS treatment can be reduced, the treatment could be cost-effective. The main limitation of this study was the short time horizon. In addition, modelling studies include assumptions, which contain uncertainty.</p><p><strong>Implications for health care provision and use: </strong>The cost-effectiveness of interventions depends on the health care decision-maker's willingness to pay. rTMS can be effective in treating depression; however, in high price level countries (high unit costs) with limited access to treatment, rTMS may not provide value for money for treating acute phase TRD patients, and it may not be recommended for public health care resources investments. It should be still noted that mental health conditions can be complex and have broad effects on an individual's life. When conducting economic evaluations of m
背景:抑郁症在世界范围内具有很高的患病率,由于其复发性,它是社会的主要经济负担。重要的是确定和评估有效的治疗方法,以避免与健康状况不佳有关的健康效用和费用。重复经颅磁刺激(rTMS)是一种临床安全、无创、有效的神经调节技术,用于治疗至少两次失败的抗抑郁药物试验后的抑郁症。在许多国家,rTMS治疗的可用性仍然有限。研究目的:主要研究目的是从社会角度评估芬兰难治性抑郁症患者附加rTMS治疗与药物治疗的成本效益。方法:采用1年马尔可夫模型,以2个月为周期,比较成本和质量调整生命年(QALYs)。医疗和生产力成本也包括在分析中。模型的数据(转换概率、资源利用率、效用)来源于已发表的文献、国家单位成本报告和芬兰专家意见。计算增量成本-效果比。不确定性评估采用单变量和多变量概率敏感性分析和情景分析。结果:与单独药物治疗相比,rTMS患者在一年的时间范围内平均获得了0.041额外的qaly,增量成本为3,514欧元。结果对应于每个QALY的增量成本效益比(ICER)为85,133欧元。敏感性分析指出,与不确定性和驱动ICER相关的关键参数之一是rTMS治疗的高单位成本。讨论:与单独的药物治疗相比,rTMS作为抑郁症的附加治疗具有有益的临床效果,但成本更高。然而,ICER非常高,表明rTMS可能不是芬兰TRD患者的经济有效的急性治疗方法。如果可以降低rTMS治疗的单位成本,则该治疗可能具有成本效益。本研究的主要局限性是时间跨度短。此外,建模研究包括假设,其中包含不确定性。对卫生保健提供和使用的影响:干预措施的成本效益取决于卫生保健决策者的支付意愿。rTMS可有效治疗抑郁症;然而,在获得治疗机会有限的高价格水平国家(单位成本高),rTMS可能无法为治疗急性期TRD患者提供物有所值的治疗,因此可能不建议将其用于公共卫生保健资源投资。应该指出的是,精神健康状况可能是复杂的,对个人的生活有广泛的影响。在对精神卫生干预措施进行经济评估时,除考虑直接医疗费用外,还必须考虑生产力成本。对卫生政策的影响:有关分配公共资金的决定和建议应要求对干预措施进行经济评价。在已有有效性数据的情况下,支持地方决策的一种方法可以是本地化和建模研究。对进一步研究的启示:在心理健康领域更需要干预措施的经济评估,以支持可持续决策。为了确保做出这些决定,还需要长期数据。
{"title":"Cost-Utility of Repetitive Transcranial Magnetic Stimulation (rTMS) among Treatment Resistant Depression Patients.","authors":"Anna-Kaisa Vartiainen, Elisa Rissanen, Ismo Linnosmaa","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Depression has a high prevalence worldwide and because of its recurrent nature, it represents a major economic burden on society. It is important to identify and evaluate effective treatments to avoid the health disutilities and costs related to poor health. Repetitive transcranial magnetic stimulation (rTMS) is a neuromodulatory technique which is clinically safe, non-invasive, and effective for major depressive disorder and it is used for treatment after at least two failed antidepressant medication trials. The availability of rTMS treatment is still limited in many countries.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aims of the study: &lt;/strong&gt;The main study objective was to evaluate the cost-effectiveness of add-on rTMS therapy compared with pharmacotherapy in patients with treatment-resistant depression in Finland from a societal perspective.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A one-year Markov-model with two-month cycles was analysed to compare costs and quality adjusted life years (QALYs). Medical and productivity costs were included in the analysis. The data for the model (transition probabilities, resource utilization, utilities) were sourced from published literature, a national unit cost report, and Finnish expert opinions. Incremental cost-effectiveness ratio was calculated. Uncertainty was assessed using univariate and multivariate probabilistic sensitivity analyses and scenario analyses.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;rTMS patients gained an average of 0.041 additional QALYs over one year time horizon with an incremental cost of 3,514 EUR compared to pharmacotherapy alone. The result corresponds to incremental cost-effectiveness ratio (ICER) of 85,133 EUR per QALY. Sensitivity analysis points out that one of the key parameters relating to uncertainty and driving ICER is the high unit cost of rTMS treatment.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Discussion: &lt;/strong&gt;rTMS as an add-on treatment for depression has a beneficial clinical effect compared to pharmacotherapy alone, with greater costs. However, ICER was very high suggesting that rTMS may not be cost-effective acute treatment for TRD patients in Finland. If the unit cost of the rTMS treatment can be reduced, the treatment could be cost-effective. The main limitation of this study was the short time horizon. In addition, modelling studies include assumptions, which contain uncertainty.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Implications for health care provision and use: &lt;/strong&gt;The cost-effectiveness of interventions depends on the health care decision-maker's willingness to pay. rTMS can be effective in treating depression; however, in high price level countries (high unit costs) with limited access to treatment, rTMS may not provide value for money for treating acute phase TRD patients, and it may not be recommended for public health care resources investments. It should be still noted that mental health conditions can be complex and have broad effects on an individual's life. When conducting economic evaluations of m","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"28 4","pages":"133-146"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146012770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PERSPECTIVE: Social Determinants: New Possibilities for Intervention Research in Global Mental Health. 观点:社会决定因素:全球心理健康干预研究的新可能性。
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2025-09-01
Crick Lund
<p><strong>Background: </strong>Since its launch in 2007, the field of global mental health has generated substantial research on the social determinants of mental health. Yet relatively little is known about how to intervene to address these social determinants: are such interventions feasible and effective? If they are effective, what are the mechanisms of these effects?</p><p><strong>Discussion: </strong>This article interrogates some of the important challenges and potential approaches to consider when intervening to address the social determinants of mental health. Challenges include distal intervention targets, opaque mechanisms, intractable political and structural challenges, the need for interdisciplinary approaches, limited currently available datasets, ethical challenges when conducting trials in this field and challenges to research funders, who may be required to fund beyond their disciplinary silos and to convene inter-disciplinary review panels. Nevertheless, several approaches hold promise. First, we need to build more robust and precise theoretical models of how specific social and economic adversities lead to mental health outcomes. This is vital to clearly identify causal mechanisms that may be targeted in interventions. Second, we must test the specific mechanisms in these hypothesized causal pathways for example through including adequately powered mediation analyses in the design of our trials. Third, data need to be shared and where appropriate, pooled across multiple sites, to provide more statistical power and to take context into consideration. Finally, clear criteria need to guide the choice of which social determinants to target.</p><p><strong>Recommendations for future research: </strong>Regarding observational studies, more research is needed to measure the intergenerational transmission of poverty and mental illness and to explore the mechanisms of poverty and mental health over time. We need to understand more about the links between gender, poverty and mental health across the life course, including genetic, biological and socioeconomic risk and protective factors. In relation to intervention studies, research is needed on interventions that address proximal and more distal mechanisms, for example the impact of living environments, climate change and migration on mental health. We are on the threshold of a new era of heightened risk for a broad range of social and economic determinants triggered by climate change, conflict and migration. There is a great deal more that we could be doing to improve our resilience and responsiveness to these challenging circumstances.</p><p><strong>Recommendations for policy: </strong>Adopting a social determinants approach requires a broadened policy agenda. Global mental health advocacy must now also campaign for improved living environments, human rights and reductions in conflict to improve the mental health of populations and reduce inequities in the distribution of mental heal
背景:自2007年启动以来,全球精神卫生领域对精神卫生的社会决定因素进行了大量研究。然而,对于如何干预以解决这些社会决定因素,我们所知相对较少:这些干预措施是否可行和有效?如果它们是有效的,这些效果的机制是什么?讨论:本文探讨了干预解决心理健康的社会决定因素时需要考虑的一些重要挑战和潜在方法。挑战包括远端的干预目标、不透明的机制、棘手的政治和结构挑战、跨学科方法的需求、有限的当前可用数据集、在该领域进行试验时面临的伦理挑战以及研究资助者面临的挑战,他们可能需要资助超出其学科范围的研究,并召集跨学科审查小组。尽管如此,有几种方法还是有希望的。首先,我们需要建立更强大和精确的理论模型,说明特定的社会和经济逆境如何导致心理健康结果。这对于明确确定干预措施可能针对的因果机制至关重要。其次,我们必须在这些假设的因果途径中测试特定的机制,例如,通过在我们的试验设计中包括充分有力的中介分析。第三,数据需要共享,并在适当的情况下跨多个站点汇集,以提供更多的统计能力并考虑上下文。最后,需要明确的标准来指导选择要针对哪些社会决定因素。对未来研究的建议:关于观察性研究,需要更多的研究来衡量贫困和精神疾病的代际传递,并探索贫困和精神健康的长期机制。我们需要更多地了解整个生命过程中性别、贫困和心理健康之间的联系,包括遗传、生物和社会经济风险和保护因素。在干预研究方面,需要研究针对近端和远端机制的干预措施,例如生活环境、气候变化和移民对心理健康的影响。我们即将进入一个新时代,气候变化、冲突和移民引发的一系列社会和经济决定因素的风险加剧。我们还可以做很多事情来提高我们对这些具有挑战性的环境的适应能力和反应能力。政策建议:采用社会决定因素方法需要扩大政策议程。全球心理健康宣传现在还必须开展改善生活环境、人权和减少冲突的运动,以改善人口的心理健康,减少心理健康分配方面的不公平现象。政策信息是双重的:投资于精神卫生保健,并投资于解决精神卫生社会决定因素的干预措施。这就需要采取基础广泛的全社会办法,同时采取干预措施,处理精神疾病的起因和后果。
{"title":"PERSPECTIVE: Social Determinants: New Possibilities for Intervention Research in Global Mental Health.","authors":"Crick Lund","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Since its launch in 2007, the field of global mental health has generated substantial research on the social determinants of mental health. Yet relatively little is known about how to intervene to address these social determinants: are such interventions feasible and effective? If they are effective, what are the mechanisms of these effects?&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Discussion: &lt;/strong&gt;This article interrogates some of the important challenges and potential approaches to consider when intervening to address the social determinants of mental health. Challenges include distal intervention targets, opaque mechanisms, intractable political and structural challenges, the need for interdisciplinary approaches, limited currently available datasets, ethical challenges when conducting trials in this field and challenges to research funders, who may be required to fund beyond their disciplinary silos and to convene inter-disciplinary review panels. Nevertheless, several approaches hold promise. First, we need to build more robust and precise theoretical models of how specific social and economic adversities lead to mental health outcomes. This is vital to clearly identify causal mechanisms that may be targeted in interventions. Second, we must test the specific mechanisms in these hypothesized causal pathways for example through including adequately powered mediation analyses in the design of our trials. Third, data need to be shared and where appropriate, pooled across multiple sites, to provide more statistical power and to take context into consideration. Finally, clear criteria need to guide the choice of which social determinants to target.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Recommendations for future research: &lt;/strong&gt;Regarding observational studies, more research is needed to measure the intergenerational transmission of poverty and mental illness and to explore the mechanisms of poverty and mental health over time. We need to understand more about the links between gender, poverty and mental health across the life course, including genetic, biological and socioeconomic risk and protective factors. In relation to intervention studies, research is needed on interventions that address proximal and more distal mechanisms, for example the impact of living environments, climate change and migration on mental health. We are on the threshold of a new era of heightened risk for a broad range of social and economic determinants triggered by climate change, conflict and migration. There is a great deal more that we could be doing to improve our resilience and responsiveness to these challenging circumstances.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Recommendations for policy: &lt;/strong&gt;Adopting a social determinants approach requires a broadened policy agenda. Global mental health advocacy must now also campaign for improved living environments, human rights and reductions in conflict to improve the mental health of populations and reduce inequities in the distribution of mental heal","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"28 3","pages":"97-103"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145193395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost Effects of Diagnose, Indicate, and Treat Severe Mental Illness (DITSMI) in Residential Psychiatry. 住院精神病学诊断、指示和治疗严重精神疾病(DITSMI)的成本效应
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2025-09-01
Mike H Veereschild, Eric O Noorthoorn, Peter Lepping, Anneke J Van der Veen, Giel J M Hutschemaekers
<p><strong>Background: </strong>The COVID-19 pandemic triggered widespread lockdown measures, including a sudden and substantial increase in working from home arrangements. While intended to reduce virus transmission, these measures may have had unintended consequences for mental health. Remote work limits in-person interactions and alters work-life boundaries, potentially influencing psychological well-being. However, empirical research on the mental health effects of working from home -especially under involuntary conditions- is still limited.</p><p><strong>Aims of the study: </strong>This study investigates the impact of working from home on mental health during the first lockdown in Germany. Specifically, it aims to differentiate between selection effects (i.e., individuals who choose working from home based on their circumstances) and causal effects (i.e., the mental health consequences of working from home itself). The goal is to understand whether working from home, when imposed rather than voluntarily chosen, negatively affects mental well-being.</p><p><strong>Methods: </strong>We use data from the Mannheim Corona Study (MCS), which collected high-frequency panel data from a representative sample of the German population during the first lockdown (March-July 2020). The analysis focuses on employed individuals and excludes those not working. We create a binary working from home indicator and analyze its association with four mental health measures: two indicators of depressive symptoms, one of loneliness, and one of social interaction frequency. Both pooled linear regressions and fixed effects models are employed to estimate associations while accounting for confounders and unobserved heterogeneity.</p><p><strong>Results: </strong>Descriptive statistics reveal that working from home was more common among individuals with higher income and education, reflecting a socioeconomic selection effect. Pooled regression results show a significant association between working from home and increased loneliness, depressive symptoms, and reduced social interaction. These associations persist even after controlling for sociodemographic characteristics. Fixed effects panel regressions-focusing on within-individual changes-confirm a significant, though smaller, negative effect of working from home on mental health, particularly regarding loneliness and loss of interest. This strengthens the evidence for a causal link between working from home and reduced psychological well-being, independent of pre-existing personal characteristics.</p><p><strong>Discussion: </strong>The findings suggest that even privileged individuals working from home experienced a decline in mental health, highlighting the psychological costs of reduced social interaction during the lockdown. Limitations include the lack of pre-pandemic mental health data and the inability to distinguish between voluntary and enforced working from home beyond the lockdown context. Also, the relatively
背景:2019冠状病毒病大流行引发了广泛的封锁措施,包括在家工作安排突然大幅增加。这些措施虽然旨在减少病毒传播,但可能对心理健康产生了意想不到的后果。远程工作限制了面对面的互动,改变了工作与生活的界限,可能会影响心理健康。然而,关于在家工作对心理健康影响的实证研究——尤其是在非自愿的情况下——仍然有限。研究目的:本研究调查了德国第一次封锁期间在家工作对心理健康的影响。具体来说,它旨在区分选择效应(即,个人根据自己的情况选择在家工作)和因果效应(即,在家工作本身的心理健康后果)。其目的是了解在家工作是否会对心理健康产生负面影响,而不是自愿选择在家工作。方法:我们使用了曼海姆冠状病毒研究(MCS)的数据,该研究在第一次封锁期间(2020年3月至7月)从德国人口的代表性样本中收集了高频面板数据。分析的重点是有工作的个人,不包括那些没有工作的人。我们创建了一个在家工作的二元指标,并分析了它与四个心理健康指标的关联:两个抑郁症状指标,一个孤独指标和一个社会互动频率指标。在考虑混杂因素和未观察到的异质性的同时,采用合并线性回归和固定效应模型来估计关联。结果:描述性统计显示,在家工作在高收入、高教育程度的个体中更为普遍,反映了社会经济选择效应。汇总回归结果显示,在家工作与孤独感增加、抑郁症状和社交互动减少之间存在显著关联。即使在控制了社会人口特征之后,这些联系仍然存在。固定效应面板回归——专注于个体内部的变化——证实了在家工作对心理健康的显著负面影响,尽管影响较小,尤其是在孤独感和失去兴趣方面。这加强了在家工作与心理健康下降之间的因果关系的证据,独立于先前的个人特征。讨论:研究结果表明,即使是享有特权的在家工作的人,心理健康状况也有所下降,这突显了封锁期间社会互动减少的心理成本。限制包括缺乏大流行前的心理健康数据,以及无法区分在封锁背景下自愿和被迫在家工作。此外,相对较短的观察期限制了对长期适应的认识。对卫生保健提供和使用的影响:卫生专业人员应考虑与远程工作环境有关的心理健康风险,特别是在强制隔离期间。早期识别有风险的个体和有针对性的支持策略可能有助于防止远程工作者的心理健康恶化。对卫生政策的影响:决策者应平衡感染控制措施及其更广泛的社会心理影响。如果远程工作成为一项长期战略,应将相应的心理健康支持机制制度化。工作场所选择的灵活性可能有助于减轻不利的心理影响。对进一步研究的启示:未来的研究应探讨具体的家庭工作条件(如工作空间质量、家庭组成)如何调节心理健康结果。有必要在封锁期之后进行纵向研究,以评估这些影响的持久性和可逆性。评估支持远程工作环境中精神卫生的干预措施也至关重要。
{"title":"Cost Effects of Diagnose, Indicate, and Treat Severe Mental Illness (DITSMI) in Residential Psychiatry.","authors":"Mike H Veereschild, Eric O Noorthoorn, Peter Lepping, Anneke J Van der Veen, Giel J M Hutschemaekers","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The COVID-19 pandemic triggered widespread lockdown measures, including a sudden and substantial increase in working from home arrangements. While intended to reduce virus transmission, these measures may have had unintended consequences for mental health. Remote work limits in-person interactions and alters work-life boundaries, potentially influencing psychological well-being. However, empirical research on the mental health effects of working from home -especially under involuntary conditions- is still limited.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aims of the study: &lt;/strong&gt;This study investigates the impact of working from home on mental health during the first lockdown in Germany. Specifically, it aims to differentiate between selection effects (i.e., individuals who choose working from home based on their circumstances) and causal effects (i.e., the mental health consequences of working from home itself). The goal is to understand whether working from home, when imposed rather than voluntarily chosen, negatively affects mental well-being.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We use data from the Mannheim Corona Study (MCS), which collected high-frequency panel data from a representative sample of the German population during the first lockdown (March-July 2020). The analysis focuses on employed individuals and excludes those not working. We create a binary working from home indicator and analyze its association with four mental health measures: two indicators of depressive symptoms, one of loneliness, and one of social interaction frequency. Both pooled linear regressions and fixed effects models are employed to estimate associations while accounting for confounders and unobserved heterogeneity.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Descriptive statistics reveal that working from home was more common among individuals with higher income and education, reflecting a socioeconomic selection effect. Pooled regression results show a significant association between working from home and increased loneliness, depressive symptoms, and reduced social interaction. These associations persist even after controlling for sociodemographic characteristics. Fixed effects panel regressions-focusing on within-individual changes-confirm a significant, though smaller, negative effect of working from home on mental health, particularly regarding loneliness and loss of interest. This strengthens the evidence for a causal link between working from home and reduced psychological well-being, independent of pre-existing personal characteristics.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Discussion: &lt;/strong&gt;The findings suggest that even privileged individuals working from home experienced a decline in mental health, highlighting the psychological costs of reduced social interaction during the lockdown. Limitations include the lack of pre-pandemic mental health data and the inability to distinguish between voluntary and enforced working from home beyond the lockdown context. Also, the relatively","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"28 3","pages":"105-116"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145193432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in Access to Substance Use Disorder Treatment Associated with the 2008 U.S. Parity Law. 与2008年美国平价法相关的物质使用障碍治疗的变化。
IF 1.6 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2025-09-01
Timothy B Creedon, Constance M Horgan, Xiaodong Liu, Dominic Hodgkin

Background: Historically, U.S. health insurance plans included fewer and more restrictive benefits for mental health (MH) and substance use disorder (SUD) treatment compared to general medical care. The 2008 Mental Health Parity and Addiction Equity Act (MHPAEA) mandated that group-based private health plans covering MH/SUD treatment do so in a way no more restrictive than coverage for general medical care. Multiple rounds of rulemaking, including 2024 final rules most recently, have strengthened federal regulation of plans' non-quantitative treatment limits (NQTLs).

Aims of the study: To investigate how SUD treatment rates, perceived unmet needs, and barriers to treatment changed for adults with group-based private insurance following MHPAEA.

Methods: We conducted a secondary analysis of annual, cross-sectional data from the National Survey on Drug Use and Health (2006-2014) with a sample of adults aged 18-64 years meeting criteria for SUD treatment need. We used difference-in-differences models to estimate and compare outcomes between adults with group-based private insurance (GBPI) and multiple comparison groups including those with individual-based private insurance (IBPI) before (2006-2009) and after (2011-2014) MHPAEA implementation.

Results: Among 32,605 survey respondents with SUD (weighted N=16,108,465), 17,065 individuals had GBPI. For this group, adjusted rates of any past-year SUD treatment remained low, and we did not detect a statistically significant change following MHPAEA implementation (6.4% pre-parity vs. 7.0% post-parity; +0.5 percentage points, 95% CI: -1.1 to 2.2, p=0.514). Difference-in-differences analysis showed no significant difference in changes between those with GBPI and those with IBPI (+3.1 percentage points, 95% CI: -3.8 to 10.0, p=0.380). Self-identified unmet SUD treatment need also remained consistently low (3.9% pre-parity vs. 3.9% post-parity; +0.1 percentage points, 95% CI: -1.0 to 1.1, p=0.895). Among GBPI enrollees reporting unmet need, no significant changes were observed in barriers related to cost (14.9% post-MHPAEA), treatment accessibility (22.8%), ambivalence about seeking treatment (66.8%), or stigma (19.1%). Only half of GBPI enrollees knew their insurance covered SUD treatment, with nearly 40% reporting they didn't know.

Discussion: These findings align with other studies of U.S. parity laws, which have found little to no impact on SUD treatment rates despite potential improvements in financial protection. Limitations include reliance on self-reported data, inability to identify specific insurance plans exempt from MHPAEA, and lack of state-level identifiers to account for pre-existing state parity laws.

Implications for health care provision and use: Providers and health systems may consider new strategies to identify SUD treatment needs and improve awareness of i

背景:历史上,与一般医疗保健相比,美国健康保险计划对精神健康(MH)和物质使用障碍(SUD)治疗的福利更少,限制更多。2008年《精神健康平等和成瘾公平法》(MHPAEA)规定,以团体为基础的涵盖精神分裂症/精神分裂症治疗的私人健康计划的限制不得超过涵盖一般医疗保健的限制。多轮规则制定,包括最近的2024年最终规则,加强了联邦对计划非定量治疗限制(nqtl)的监管。研究目的:调查在MHPAEA之后,以团体为基础的私人保险的成年人的SUD治疗率、未满足的需求和治疗障碍是如何变化的。方法:我们对2006-2014年全国药物使用与健康调查(National Survey on Drug Use and Health)的年度横断面数据进行了二次分析,样本为年龄在18-64岁、符合SUD治疗需求标准的成年人。我们使用差异中的差异模型来估计和比较在实施MHPAEA之前(2006-2009)和之后(2011-2014),以团体为基础的私人保险(GBPI)的成年人和以个人为基础的私人保险(IBPI)的多个对照组的结果。结果:在32,605名患有SUD的调查对象中(加权N=16,108,465),有17,065人患有GBPI。对于这一组,过去一年任何SUD治疗的调整率仍然很低,并且我们没有发现实施MHPAEA后的统计学显著变化(胎前6.4% vs胎后7.0%;+0.5个百分点,95% CI: -1.1至2.2,p=0.514)。差异中差异分析显示,GBPI患者与IBPI患者的变化无显著差异(+3.1个百分点,95% CI: -3.8至10.0,p=0.380)。自我认定未满足的SUD治疗需求也保持在较低水平(胎前3.9% vs胎后3.9%;+0.1个百分点,95% CI: -1.0至1.1,p=0.895)。在报告未满足需求的GBPI入组者中,与费用(14.9%)、治疗可及性(22.8%)、寻求治疗的矛盾心理(66.8%)或耻辱感(19.1%)相关的障碍未观察到显著变化。只有一半的GBPI参与者知道他们的保险涵盖了SUD治疗,近40%的人表示他们不知道。讨论:这些发现与美国平价法的其他研究一致,这些研究发现,尽管在财务保护方面有潜在的改善,但对SUD的治愈率几乎没有影响。限制包括依赖于自我报告的数据,无法识别不受MHPAEA限制的特定保险计划,以及缺乏州级标识符来解释已有的州平价法律。对医疗保健提供和使用的影响:提供者和卫生系统可以考虑新的策略来确定SUD治疗需求,并提高患者对保险覆盖范围的认识,因为近四成的团体私人保险和SUD患者不知道他们的SUD覆盖范围。对卫生政策的影响:虽然最近的MHPAEA最终规则加强了执行机制并禁止限制性nqtl,但我们的研究结果表明,可能需要额外的政策来改善SUD治疗的可及性,包括努力提高对治疗需求和覆盖范围的认识,减少耻辱感,并提高治疗的可获得性。对进一步研究的影响:未来的研究可以研究2024年MHPAEA最终规则如何影响nqtl,并调查MHPAEA与其他医疗改革对SUD治疗可及性的综合影响,以及克服治疗持续非经济障碍的策略。
{"title":"Changes in Access to Substance Use Disorder Treatment Associated with the 2008 U.S. Parity Law.","authors":"Timothy B Creedon, Constance M Horgan, Xiaodong Liu, Dominic Hodgkin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Historically, U.S. health insurance plans included fewer and more restrictive benefits for mental health (MH) and substance use disorder (SUD) treatment compared to general medical care. The 2008 Mental Health Parity and Addiction Equity Act (MHPAEA) mandated that group-based private health plans covering MH/SUD treatment do so in a way no more restrictive than coverage for general medical care. Multiple rounds of rulemaking, including 2024 final rules most recently, have strengthened federal regulation of plans' non-quantitative treatment limits (NQTLs).</p><p><strong>Aims of the study: </strong>To investigate how SUD treatment rates, perceived unmet needs, and barriers to treatment changed for adults with group-based private insurance following MHPAEA.</p><p><strong>Methods: </strong>We conducted a secondary analysis of annual, cross-sectional data from the National Survey on Drug Use and Health (2006-2014) with a sample of adults aged 18-64 years meeting criteria for SUD treatment need. We used difference-in-differences models to estimate and compare outcomes between adults with group-based private insurance (GBPI) and multiple comparison groups including those with individual-based private insurance (IBPI) before (2006-2009) and after (2011-2014) MHPAEA implementation.</p><p><strong>Results: </strong>Among 32,605 survey respondents with SUD (weighted N=16,108,465), 17,065 individuals had GBPI. For this group, adjusted rates of any past-year SUD treatment remained low, and we did not detect a statistically significant change following MHPAEA implementation (6.4% pre-parity vs. 7.0% post-parity; +0.5 percentage points, 95% CI: -1.1 to 2.2, p=0.514). Difference-in-differences analysis showed no significant difference in changes between those with GBPI and those with IBPI (+3.1 percentage points, 95% CI: -3.8 to 10.0, p=0.380). Self-identified unmet SUD treatment need also remained consistently low (3.9% pre-parity vs. 3.9% post-parity; +0.1 percentage points, 95% CI: -1.0 to 1.1, p=0.895). Among GBPI enrollees reporting unmet need, no significant changes were observed in barriers related to cost (14.9% post-MHPAEA), treatment accessibility (22.8%), ambivalence about seeking treatment (66.8%), or stigma (19.1%). Only half of GBPI enrollees knew their insurance covered SUD treatment, with nearly 40% reporting they didn't know.</p><p><strong>Discussion: </strong>These findings align with other studies of U.S. parity laws, which have found little to no impact on SUD treatment rates despite potential improvements in financial protection. Limitations include reliance on self-reported data, inability to identify specific insurance plans exempt from MHPAEA, and lack of state-level identifiers to account for pre-existing state parity laws.</p><p><strong>Implications for health care provision and use: </strong>Providers and health systems may consider new strategies to identify SUD treatment needs and improve awareness of i","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"28 3","pages":"77-96"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145193424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PERSPECTIVE: Improving Suicide Prevention Strategies and Interventions: A Co-produced Perspective. 观点:改善自杀预防策略和干预措施:共同制作的观点。
IF 1 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2025-06-01
Anton N Isaacs, Samantha McIntosh

Background: Suicide continues to be a major problem worldwide. Persons with a lived experience are being actively involved in suicide research and reports suggest that co-production of suicide research with persons with a lived experience significantly improves its quality and appropriateness.

Aims of the study: The aims of this paper are (i) To identify challenges to Australian suicide prevention strategies and interventions and (ii) To offer recommendations to address these challenges.

Methods: This perspective article is a co-production between an experienced mental health researcher and a person with a lived experience of suicidality, who has worked as a suicide prevention worker and has held leadership positions in government and non-government suicide prevention programs.

Results: Challenges to Australian suicide prevention strategies and interventions include: the careless reporting of suicide in the media, the continuing stigma in seeking help, stigma as a barrier to gatekeeper training, the entry point of suicide prevention services and care of those with suicidal ideation/attempt. Recommendations include: that media must consider the responsible reporting of suicide as a duty of care; that the community response to help-seeking for suicide needs to be one of compassion; that gatekeeper training should be expanded to be universally accessible and messaging in suicide prevention training programs must pay attention to its rationale; that services for those with suicide ideation and attempt must commence with providing a safe space and empathetic support by peer workers and that continuing care after suicidal attempt must be informed by the individual's needs and include informal and family carers, as well as other community agencies.

Discussion: Stigma related to suicide continues to be a major barrier to help seeking and suicide prevention training. The approach to suicide prevention and intervention services needs to focus on stigma reduction, responsible reporting by media and a person-centred approach to care. The perspectives identified here are by no means comprehensive but are merely our observations that we believe, need attention.

Implications for health care provision and use: These perspectives have implications for the early identification and assistance of those at risk of suicide in the community as well as for suicide intervention services.

Implications for health policies: These perspectives have implications for policies related to public health education including the expansion of gatekeeper training, journalism and media, as well as national and state suicide prevention strategies.

Implications for further research: Further research might focus on suicide related stigma reduction measures within communities, improved suicide intervention serv

背景:自杀仍然是世界范围内的一个主要问题。有生活经历的人正在积极参与自杀研究,报告表明,与有生活经历的人共同进行自杀研究可以显著提高研究的质量和适宜性。研究目的:本文的目的是(i)确定澳大利亚自杀预防策略和干预措施的挑战,(ii)提出解决这些挑战的建议。方法:这篇观点文章是由一位经验丰富的心理健康研究者和一位有自杀生活经验的人共同完成的,这位人曾担任自杀预防工作者,并在政府和非政府自杀预防项目中担任领导职务。结果:澳大利亚自杀预防策略和干预措施面临的挑战包括:媒体对自杀的粗心报道,寻求帮助的持续耻辱,耻辱作为看门人培训的障碍,自杀预防服务的切入点和对自杀意念/企图者的护理。建议包括:媒体必须将负责任的自杀报道视为一种注意义务;社区对寻求自杀帮助的反应需要是一种同情;看门人培训应该扩大到普遍可及的范围,自杀预防培训项目的信息传递必须注意其基本原理;对有自杀意念和企图者的服务必须从提供安全空间和同伴工作者的同情支持开始,自杀企图后的持续护理必须根据个人的需要,包括非正式和家庭照顾者以及其他社区机构。讨论:与自杀有关的耻辱仍然是寻求帮助和自杀预防培训的主要障碍。自杀预防和干预服务的方法需要侧重于减少耻辱、媒体负责任的报道和以人为本的护理方法。这里确定的观点绝不是全面的,而仅仅是我们认为需要注意的观察结果。对卫生保健提供和使用的影响:这些观点对社区中有自杀风险的人的早期识别和援助以及自杀干预服务具有影响。对卫生政策的影响:这些观点对与公共卫生教育有关的政策有影响,包括扩大看门人培训、新闻和媒体以及国家和州预防自杀战略。对进一步研究的启示:进一步的研究可能侧重于社区内与自杀相关的污名减少措施,改善自杀干预服务,以及自杀未遂后的持续护理。
{"title":"PERSPECTIVE: Improving Suicide Prevention Strategies and Interventions: A Co-produced Perspective.","authors":"Anton N Isaacs, Samantha McIntosh","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Suicide continues to be a major problem worldwide. Persons with a lived experience are being actively involved in suicide research and reports suggest that co-production of suicide research with persons with a lived experience significantly improves its quality and appropriateness.</p><p><strong>Aims of the study: </strong>The aims of this paper are (i) To identify challenges to Australian suicide prevention strategies and interventions and (ii) To offer recommendations to address these challenges.</p><p><strong>Methods: </strong>This perspective article is a co-production between an experienced mental health researcher and a person with a lived experience of suicidality, who has worked as a suicide prevention worker and has held leadership positions in government and non-government suicide prevention programs.</p><p><strong>Results: </strong>Challenges to Australian suicide prevention strategies and interventions include: the careless reporting of suicide in the media, the continuing stigma in seeking help, stigma as a barrier to gatekeeper training, the entry point of suicide prevention services and care of those with suicidal ideation/attempt. Recommendations include: that media must consider the responsible reporting of suicide as a duty of care; that the community response to help-seeking for suicide needs to be one of compassion; that gatekeeper training should be expanded to be universally accessible and messaging in suicide prevention training programs must pay attention to its rationale; that services for those with suicide ideation and attempt must commence with providing a safe space and empathetic support by peer workers and that continuing care after suicidal attempt must be informed by the individual's needs and include informal and family carers, as well as other community agencies.</p><p><strong>Discussion: </strong>Stigma related to suicide continues to be a major barrier to help seeking and suicide prevention training. The approach to suicide prevention and intervention services needs to focus on stigma reduction, responsible reporting by media and a person-centred approach to care. The perspectives identified here are by no means comprehensive but are merely our observations that we believe, need attention.</p><p><strong>Implications for health care provision and use: </strong>These perspectives have implications for the early identification and assistance of those at risk of suicide in the community as well as for suicide intervention services.</p><p><strong>Implications for health policies: </strong>These perspectives have implications for policies related to public health education including the expansion of gatekeeper training, journalism and media, as well as national and state suicide prevention strategies.</p><p><strong>Implications for further research: </strong>Further research might focus on suicide related stigma reduction measures within communities, improved suicide intervention serv","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"28 2","pages":"59-66"},"PeriodicalIF":1.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144498353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Economic Burden of Major Depressive Disorder (MDD), Panic Anxiety, and Generalized Anxiety Disorder (GAD). 重度抑郁障碍(MDD)、恐慌焦虑和广泛性焦虑障碍(GAD)的经济负担。
IF 1 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2025-06-01
Ali Abdollahi Najand Asl, Ali Imani, Mostafa Farahbakhsh, Parvin Sarbakhsh
<p><strong>Background: </strong>Considering the importance of depression and anxiety disorders in the new century and one of the important causes of disability and lost years worldwide and imposing a huge cost on the global economy, economic burden studies to determine the location of costs and the consumption of medical resources in recent years have contributed a lot to health policymaking. During the studies, it was found that the prevalence of these disorders increased significantly in Iran. This reason, along with the difference in the results of studies on the economic burden of depression and anxiety published in Iran in recent years, was one of the reasons for conducting a study of the economic burden related to these disorders in the East Azarbaijan province of Iran.</p><p><strong>Method: </strong> A retrospective, non-interventional, cross-sectional, social perspective study was conducted using a bottom-up approach for direct costs and a human capital approach for indirect costs. The data was collected from outpatients over the first four months of 2022 and from inpatients over the first nine months of the same year. Patients without age limits and suffering from at least one major depressive disorder (F32.0-F33.9), panic anxiety (F41.0), and generalized anxiety disorder (F41.1) and natives of East Azerbaijan province were included in the study. In the study for direct costs, the cost of measures that are paid directly in the process of diagnosis and treatment (medical and non-medical) were examined separately for outpatients and inpatients. For indirect costs, lost productivity due to absenteeism and premature death was calculated. For outpatients, a researcher's fee checklist form was made, and for the data of inpatients, the financial statement available in the medical file of the hospital's accounting system was used. Razi Tabriz and Imam Khomeini Benab hospitals and mental health centers of Tabriz were used as public centers, and specialist psychiatrists' offices of Tabriz were used as private centers. Patients with more than one comorbidity were excluded from the study. Total costs are reported at purchasing power parity rates.</p><p><strong>Results: </strong> The data of 145 outpatients and 198 inpatients were analyzed to calculate the economic burden of MDD, Panic Anxiety, and GAD. The total economic burden for these disorders was obtained by 142.2 million purchasing power parity (ppp) dollars in 2022 for the East Azarbaijan province of Iran, with a population of more than 3.5 million people. The economic burden was divided into direct costs of 35.4 million dollars ppp and indirect costs of 106.79 million dollars ppp, representing 24.9% and 75.1%, respectively. The share of direct expenses of the outpatient group is 23.1% of this percentage, and the remaining 1.8% is for the inpatient group. In the case of indirect cost, from the percentage related to this sector, the share of lost productivity due to lost working days is 65.84%
背景:考虑到抑郁症和焦虑症在新世纪的重要性,以及在世界范围内导致残疾和损失寿命的重要原因之一,并给全球经济造成巨大的成本,近年来确定成本和医疗资源消耗的经济负担研究对卫生政策的制定做出了很大贡献。在研究期间,发现这些疾病的患病率在伊朗显著增加。这一原因,以及近年来在伊朗发表的关于抑郁和焦虑经济负担的研究结果的差异,是在伊朗东阿塞拜疆省对与这些疾病有关的经济负担进行研究的原因之一。方法:采用自下而上的方法计算直接成本,采用人力资本方法计算间接成本,采用回顾性、非干入性、横断面、社会视角研究。这些数据是从2022年前4个月的门诊患者和同年前9个月的住院患者中收集的。无年龄限制且患有至少一种重度抑郁症(F32.0-F33.9)、恐慌焦虑(F41.0)和广泛性焦虑症(F41.1)的患者和东阿塞拜疆省的本地人被纳入研究。在直接费用研究中,分别对门诊和住院患者在诊疗(医疗和非医疗)过程中直接支付的措施费用进行了检查。对于间接成本,计算了因缺勤和过早死亡造成的生产力损失。对于门诊患者,我们制作了研究员费用清单表,对于住院患者的数据,我们使用医院会计系统医疗档案中的财务报表。大不里士的拉齐医院和伊玛目霍梅尼医院和大不里士的精神保健中心被用作公共中心,大不里士的专家精神病医生办公室被用作私人中心。有一种以上合并症的患者被排除在研究之外。总成本按购买力平价计算。结果:分析了145例门诊患者和198例住院患者的数据,计算了MDD、恐慌焦虑和GAD的经济负担。这些疾病造成的经济负担总额为2022年伊朗东阿塞拜疆省(人口超过350万)的1.422亿购买力平价美元。经济负担分为直接成本3540万美元,间接成本10679万美元,分别占24.9%和75.1%。其中,门诊组直接费用占23.1%,住院组直接费用占1.8%。就间接成本而言,从与该部门有关的百分比来看,由于工作日损失造成的生产力损失份额为65.84%,由于过早死亡造成的生产力损失份额为9.26%。在门诊组中,药品费用占人均成本的58.64%,在住院组中,患者住宿费用占人均直接成本的55.63%,精神科医生的就诊费用占人均住院直接成本的20.34%,这些人自己分配的直接成本份额最大。根据本研究采用的方法,总成本分别对人均GDP (ppp)、焦虑患病率和抑郁患病率敏感度最高。结论:根据研究结果,很明显,间接成本占经济负担的很大一部分。此外,虽然住院患者的直接成本高于门诊患者的直接成本,但由于门诊患者和住院患者数量的差异,门诊患者的直接成本在疾病总成本中所占的份额更大。考虑到患者的平均年龄和与退休年龄的巨大年龄差距,卫生政策制定者应该采取必要的措施来应对和防止不断增加的成本。
{"title":"Economic Burden of Major Depressive Disorder (MDD), Panic Anxiety, and Generalized Anxiety Disorder (GAD).","authors":"Ali Abdollahi Najand Asl, Ali Imani, Mostafa Farahbakhsh, Parvin Sarbakhsh","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Considering the importance of depression and anxiety disorders in the new century and one of the important causes of disability and lost years worldwide and imposing a huge cost on the global economy, economic burden studies to determine the location of costs and the consumption of medical resources in recent years have contributed a lot to health policymaking. During the studies, it was found that the prevalence of these disorders increased significantly in Iran. This reason, along with the difference in the results of studies on the economic burden of depression and anxiety published in Iran in recent years, was one of the reasons for conducting a study of the economic burden related to these disorders in the East Azarbaijan province of Iran.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Method: &lt;/strong&gt; A retrospective, non-interventional, cross-sectional, social perspective study was conducted using a bottom-up approach for direct costs and a human capital approach for indirect costs. The data was collected from outpatients over the first four months of 2022 and from inpatients over the first nine months of the same year. Patients without age limits and suffering from at least one major depressive disorder (F32.0-F33.9), panic anxiety (F41.0), and generalized anxiety disorder (F41.1) and natives of East Azerbaijan province were included in the study. In the study for direct costs, the cost of measures that are paid directly in the process of diagnosis and treatment (medical and non-medical) were examined separately for outpatients and inpatients. For indirect costs, lost productivity due to absenteeism and premature death was calculated. For outpatients, a researcher's fee checklist form was made, and for the data of inpatients, the financial statement available in the medical file of the hospital's accounting system was used. Razi Tabriz and Imam Khomeini Benab hospitals and mental health centers of Tabriz were used as public centers, and specialist psychiatrists' offices of Tabriz were used as private centers. Patients with more than one comorbidity were excluded from the study. Total costs are reported at purchasing power parity rates.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt; The data of 145 outpatients and 198 inpatients were analyzed to calculate the economic burden of MDD, Panic Anxiety, and GAD. The total economic burden for these disorders was obtained by 142.2 million purchasing power parity (ppp) dollars in 2022 for the East Azarbaijan province of Iran, with a population of more than 3.5 million people. The economic burden was divided into direct costs of 35.4 million dollars ppp and indirect costs of 106.79 million dollars ppp, representing 24.9% and 75.1%, respectively. The share of direct expenses of the outpatient group is 23.1% of this percentage, and the remaining 1.8% is for the inpatient group. In the case of indirect cost, from the percentage related to this sector, the share of lost productivity due to lost working days is 65.84%","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"28 2","pages":"51-58"},"PeriodicalIF":1.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144498352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Work from Home and Mental Health: Evidence from the First Lockdown. 在家工作与心理健康:来自第一次禁闭的证据。
IF 1 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2025-06-01
Kai Kruk

Background: The COVID-19 pandemic triggered widespread lockdown measures, including a sudden and substantial increase in working from home arrangements. While intended to reduce virus transmission, these measures may have had unintended consequences for mental health. Remote work limits in-person interactions and alters work-life boundaries, potentially influencing psychological well-being. However, empirical research on the mental health effects of working from home -especially under involuntary conditions- is still limited.

Aims of the study: This study investigates the impact of working from home on mental health during the first lockdown in Germany. Specifically, it aims to differentiate between selection effects (i.e., individuals who choose working from home based on their circumstances) and causal effects (i.e., the mental health consequences of working from home itself). The goal is to understand whether working from home, when imposed rather than voluntarily chosen, negatively affects mental well-being.

Methods: We use data from the Mannheim Corona Study (MCS), which collected high-frequency panel data from a representative sample of the German population during the first lockdown (March-July 2020). The analysis focuses on employed individuals and excludes those not working. We create a binary working from home indicator and analyze its association with four mental health measures: two indicators of depressive symptoms, one of loneliness, and one of social interaction frequency. Both pooled linear regressions and fixed effects models are employed to estimate associations while accounting for confounders and unobserved heterogeneity.

Results: Descriptive statistics reveal that working from home was more common among individuals with higher income and education, reflecting a socioeconomic selection effect. Pooled regression results show a significant association between working from home and increased loneliness, depressive symptoms, and reduced social interaction. These associations persist even after controlling for sociodemographic characteristics. Fixed effects panel regressions-focusing on within-individual changes-confirm a significant, though smaller, negative effect of working from home on mental health, particularly regarding loneliness and loss of interest. This strengthens the evidence for a causal link between working from home and reduced psychological well-being, independent of pre-existing personal characteristics.

Discussion: The findings suggest that even privileged individuals working from home experienced a decline in mental health, highlighting the psychological costs of reduced social interaction during the lockdown. Limitations include the lack of pre-pandemic mental health data and the inability to distinguish between voluntary and enforced working from home beyond the lockdown context. Also, the relatively

背景:2019冠状病毒病大流行引发了广泛的封锁措施,包括在家工作安排突然大幅增加。这些措施虽然旨在减少病毒传播,但可能对心理健康产生了意想不到的后果。远程工作限制了面对面的互动,改变了工作与生活的界限,可能会影响心理健康。然而,关于在家工作对心理健康影响的实证研究——尤其是在非自愿的情况下——仍然有限。研究目的:本研究调查了德国第一次封锁期间在家工作对心理健康的影响。具体来说,它旨在区分选择效应(即,个人根据自己的情况选择在家工作)和因果效应(即,在家工作本身的心理健康后果)。其目的是了解在家工作是否会对心理健康产生负面影响,而不是自愿选择在家工作。方法:我们使用了曼海姆冠状病毒研究(MCS)的数据,该研究在第一次封锁期间(2020年3月至7月)从德国人口的代表性样本中收集了高频面板数据。分析的重点是有工作的个人,不包括那些没有工作的人。我们创建了一个在家工作的二元指标,并分析了它与四个心理健康指标的关联:两个抑郁症状指标,一个孤独指标和一个社会互动频率指标。在考虑混杂因素和未观察到的异质性的同时,采用合并线性回归和固定效应模型来估计关联。结果:描述性统计显示,在家工作在高收入、高教育程度的个体中更为普遍,反映了社会经济选择效应。汇总回归结果显示,在家工作与孤独感增加、抑郁症状和社交互动减少之间存在显著关联。即使在控制了社会人口特征之后,这些联系仍然存在。固定效应面板回归——专注于个体内部的变化——证实了在家工作对心理健康的显著负面影响,尽管影响较小,尤其是在孤独感和失去兴趣方面。这加强了在家工作与心理健康下降之间的因果关系的证据,独立于先前的个人特征。讨论:研究结果表明,即使是享有特权的在家工作的人,心理健康状况也有所下降,这突显了封锁期间社会互动减少的心理成本。限制包括缺乏大流行前的心理健康数据,以及无法区分在封锁背景下自愿和被迫在家工作。此外,相对较短的观察期限制了对长期适应的认识。对卫生保健提供和使用的影响:卫生专业人员应考虑与远程工作环境有关的心理健康风险,特别是在强制隔离期间。早期识别有风险的个体和有针对性的支持策略可能有助于防止远程工作者的心理健康恶化。对卫生政策的影响:决策者应平衡感染控制措施及其更广泛的社会心理影响。如果远程工作成为一项长期战略,应将相应的心理健康支持机制制度化。工作场所选择的灵活性可能有助于减轻不利的心理影响。对进一步研究的启示:未来的研究应探讨具体的家庭工作条件(如工作空间质量、家庭组成)如何调节心理健康结果。有必要在封锁期之后进行纵向研究,以评估这些影响的持久性和可逆性。评估支持远程工作环境中精神卫生的干预措施也至关重要。
{"title":"Work from Home and Mental Health: Evidence from the First Lockdown.","authors":"Kai Kruk","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The COVID-19 pandemic triggered widespread lockdown measures, including a sudden and substantial increase in working from home arrangements. While intended to reduce virus transmission, these measures may have had unintended consequences for mental health. Remote work limits in-person interactions and alters work-life boundaries, potentially influencing psychological well-being. However, empirical research on the mental health effects of working from home -especially under involuntary conditions- is still limited.</p><p><strong>Aims of the study: </strong>This study investigates the impact of working from home on mental health during the first lockdown in Germany. Specifically, it aims to differentiate between selection effects (i.e., individuals who choose working from home based on their circumstances) and causal effects (i.e., the mental health consequences of working from home itself). The goal is to understand whether working from home, when imposed rather than voluntarily chosen, negatively affects mental well-being.</p><p><strong>Methods: </strong>We use data from the Mannheim Corona Study (MCS), which collected high-frequency panel data from a representative sample of the German population during the first lockdown (March-July 2020). The analysis focuses on employed individuals and excludes those not working. We create a binary working from home indicator and analyze its association with four mental health measures: two indicators of depressive symptoms, one of loneliness, and one of social interaction frequency. Both pooled linear regressions and fixed effects models are employed to estimate associations while accounting for confounders and unobserved heterogeneity.</p><p><strong>Results: </strong>Descriptive statistics reveal that working from home was more common among individuals with higher income and education, reflecting a socioeconomic selection effect. Pooled regression results show a significant association between working from home and increased loneliness, depressive symptoms, and reduced social interaction. These associations persist even after controlling for sociodemographic characteristics. Fixed effects panel regressions-focusing on within-individual changes-confirm a significant, though smaller, negative effect of working from home on mental health, particularly regarding loneliness and loss of interest. This strengthens the evidence for a causal link between working from home and reduced psychological well-being, independent of pre-existing personal characteristics.</p><p><strong>Discussion: </strong>The findings suggest that even privileged individuals working from home experienced a decline in mental health, highlighting the psychological costs of reduced social interaction during the lockdown. Limitations include the lack of pre-pandemic mental health data and the inability to distinguish between voluntary and enforced working from home beyond the lockdown context. Also, the relatively","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"28 2","pages":"67-72"},"PeriodicalIF":1.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144498354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do Current and Lifetime Mental Health Issues Influence Subjective Social Status? 当前和终生的心理健康问题会影响主观社会地位吗?
IF 1 4区 医学 Q4 HEALTH POLICY & SERVICES Pub Date : 2025-03-01
Michael T French, Karoline Mortensen, Yang Wen

Background: Mental health issues can impact overall health status, personal relationships, workplace productivity, and other outcomes.

Aims of the study: The primary objective of this study is to determine whether recent and lifetime mental health problems are significantly related to respondents' subjective social status (SSS).

Methods: Respondents to Waves IV (2008-2009) and V (2016-2018) of the National Longitudinal Survey of Adolescent to Adult Health (Add Health) provide the data for our research. Our empirical approach estimates Spearman correlation coefficients between self-reported mental health measures and SSS followed by multivariate regression models. The final empirical models estimate fixed-effects regressions to control for potential bias due to time-invariant unobserved heterogeneity. SSS is measured on a scale from 1 to 10, with 10 indicating perceived highest place in society.

Results: All four explanatory mental health measures (ever been diagnosed with depression, ever been diagnosed with PTSD, ever been diagnosed with anxiety or panic disorder, and past 12 month psychological or emotional counseling) are negatively and significantly (p < 0.05) associated with the outcome variable, SSS.

Discussion: Relative placement in society is associated with overall health and well-being. This study contributes in a methodologically meaningful way to the existing literature by employing empirically advanced statistical techniques to panel data. The main findings clearly demonstrate that mental health issues are negatively associated with SSS.

Implications: These findings have important policy implications for mental health counselors, employers, and society in general as mental health problems become more common and less stigmatized in the U.S.

背景:心理健康问题会影响整体健康状况、人际关系、工作效率和其他结果。研究目的:本研究的主要目的是确定近期和终生的心理健康问题是否与被调查者的主观社会地位(SSS)显著相关。方法:全国青少年成人健康纵向调查(Add Health)第四波(2008-2009)和第五波(2016-2018)的调查对象为我们的研究提供数据。我们的实证方法估计了自我报告的心理健康测量与SSS之间的Spearman相关系数,并采用多变量回归模型。最后的经验模型估计固定效应回归,以控制由于时不变的未观察到的异质性造成的潜在偏差。SSS的测量范围从1到10,10表示认为在社会中处于最高地位。结果:所有四项解释性心理健康测量(曾被诊断为抑郁症、曾被诊断为创伤后应激障碍、曾被诊断为焦虑或惊恐障碍、过去12个月的心理或情绪咨询)与结果变量SSS呈显著负相关(p < 0.05)。讨论:在社会中的相对地位与整体健康和福祉有关。本研究通过采用经验先进的统计技术对面板数据进行分析,为现有文献提供了有意义的方法。主要研究结果清楚地表明,心理健康问题与SSS呈负相关。启示:随着心理健康问题在美国变得越来越普遍,越来越少被污名化,这些发现对心理健康咨询师、雇主和整个社会具有重要的政策启示
{"title":"Do Current and Lifetime Mental Health Issues Influence Subjective Social Status?","authors":"Michael T French, Karoline Mortensen, Yang Wen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Mental health issues can impact overall health status, personal relationships, workplace productivity, and other outcomes.</p><p><strong>Aims of the study: </strong>The primary objective of this study is to determine whether recent and lifetime mental health problems are significantly related to respondents' subjective social status (SSS).</p><p><strong>Methods: </strong>Respondents to Waves IV (2008-2009) and V (2016-2018) of the National Longitudinal Survey of Adolescent to Adult Health (Add Health) provide the data for our research. Our empirical approach estimates Spearman correlation coefficients between self-reported mental health measures and SSS followed by multivariate regression models. The final empirical models estimate fixed-effects regressions to control for potential bias due to time-invariant unobserved heterogeneity. SSS is measured on a scale from 1 to 10, with 10 indicating perceived highest place in society.</p><p><strong>Results: </strong>All four explanatory mental health measures (ever been diagnosed with depression, ever been diagnosed with PTSD, ever been diagnosed with anxiety or panic disorder, and past 12 month psychological or emotional counseling) are negatively and significantly (p < 0.05) associated with the outcome variable, SSS.</p><p><strong>Discussion: </strong>Relative placement in society is associated with overall health and well-being. This study contributes in a methodologically meaningful way to the existing literature by employing empirically advanced statistical techniques to panel data. The main findings clearly demonstrate that mental health issues are negatively associated with SSS.</p><p><strong>Implications: </strong>These findings have important policy implications for mental health counselors, employers, and society in general as mental health problems become more common and less stigmatized in the U.S.</p>","PeriodicalId":46381,"journal":{"name":"Journal of Mental Health Policy and Economics","volume":"28 1","pages":"17-32"},"PeriodicalIF":1.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143558332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Mental Health Policy and Economics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1